BYJU'S $200 million rights issue fully subscribed: CEO Byju Raveendran
The Hindu
BYJU'S CEO announces successful $200 million rights issue, urges all shareholders to participate in renewed mission.
Edtech major BYJU'S top official said the company's $200 million rights issue has been fully subscribed and asked all shareholders to participate in the "renewed mission".
Think and Learn Private Limited, which operates under BYJU'S brand name, has floated $200 million rights issue at less than 99% enterprise valuation compared to its peak valuation of $22 billion.
"Our rights issue is fully subscribed and my gratitude to my shareholders remains strong. But my benchmark of success is the participation of all shareholders in the rights issue. We have built this company together and I want us all to participate in this renewed mission," BYJU'S Founder and CEO Byju Raveendran said in a letter to shareholders.
Mr. Raveendran said that the company will appoint a third-party agency to monitor the usage of funds raised through the rights issue. "The ownership of the company does not change pre and post a rights issue, so the question of valuation itself is irrelevant as value preservation is maintained," he said.
The comment assumes significance as a group of shareholders, who jointly hold around 30% stake in BYJU'S, have called for an extraordinary general meeting (EGM) to oust top management alleging several anomalies under their leadership.
"A few vested interests are misrepresenting our relationship as adversarial. Let me be unequivocal in stating that such narratives could not be further from the truth. There is nothing to be gained from conflict, especially with those who share our commitment and conviction towards our common cause," he said.
He said that he will not allow "self-serving actions of a few individuals" cloud his judgment and pollute the relationship among shareholders.
Rupee hits all-time low at 85.20 against USD due to strong greenback, rising crude oil prices, and weak domestic markets.
Viatris faces U.S. FDA import alert for products from Indore plant, exceptions made for certain shortages.
xAI’s Grok may soon come to an iOS app as the company announced its Series C funding round of $6 billion.
Biocon and Zentiva receive EU approval for Liraglutide, a complex formulation for diabetes and weight management.
Equity markets fluctuate as Sensex and Nifty rise initially, then fall; global markets and oil prices also discussed.
Microsoft has been working on adding internal and third-party AI models to power Microsoft 365 Copilot.
China's dominance in critical minerals poses supply chain vulnerabilities for India, US, and EU nations, requiring strategic diversification efforts.
India's controversial popcorn tax system sparks outrage and criticism, with opposition questioning the complex GST rates.
ICAI President investigates auditing lapses at Byju's, disciplinary committee probing, details undisclosed, part of ongoing investigations.
Sensex and Nifty rebound sharply after steep decline, driven by value buying, bluechip stocks, and global market rally.
AS-IT-IS Nutrition aims for ₹300 crore GMV in 2025 with ATOM range, endorsed by Ravindra Jadeja.